X chromatin, endomitoses, and mitotic abnormalities in human cervical cancer.
The incidence of X chromatin bodies and mitotic modifications and aberrations has been analyzed using Feulgen-squash preparations in 47 cervical cancers from Helsinki and 35 from Madison. Sixteen of the 82 tumors did not display any X chromatin bodies, and some others showed a lower than normal frequency, especially in the large nuclei. Different hypotheses to explain the absence of Barr bodies in female tumors have been reviewed. A new observation is that 44/82 tumors contained endomitoses. The metaphase/prophase ratio (M/P) was higher than 1.5 in all but three cases, reaching values as high as 23.0 (Madison) and 34.2 (Helsinki), and in one exceptional case, 51.8. The different types of cells, mitotic, endomitotic, and those with large to giant nuclei, form their own strands or layers. Cervical cancer is diagnosed earlier in Finland than in Madison due to a Pap mass screening program, and consequently, the survival of the patients after 5 years was 27/47 in Helsinki and 6/35 in Madison. No correlation could be established between the M/P (or other mitotic phenomena) or the stage and grade of the tumor, the age of the patient, or survival time.
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008677:Metaphase; D008875:Middle Aged; D008938:Mitosis; D009367:Neoplasm Staging; D011418:Prophase; D012728:Sex Chromatin; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000473:pathology; D014960:X Chromosome